{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:42:30Z","timestamp":1783636950176,"version":"3.55.0"},"reference-count":85,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2017.00250","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T03:44:21Z","timestamp":1501645461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Md. Asiful","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teguh Haryo","family":"Sasongko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Keng","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.2174\/1381612822666160527160236","article-title":"Type 2 diabetes mellitus and Alzheimer\u2019s disease: bridging the pathophysiology and management.","volume":"22","author":"Alam","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/rheumatology\/keh722","article-title":"Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model.","volume":"44","author":"Alves","year":"2005","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.neuroimage.2006.09.029","article-title":"Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.","volume":"34","author":"Appenzeller","year":"2007","journal-title":"Neuroimage"},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11926-011-0224-4","article-title":"Cognitive dysfunction and antiphospholipid antibodies.","volume":"14","author":"Appenzeller","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000342761","article-title":"Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.","volume":"40","author":"Arvanitakis","year":"2012","journal-title":"Neuroepidemiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.46.8.605","article-title":"Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.","volume":"46","author":"Asherson","year":"1987","journal-title":"Ann. Rheum. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications.","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00002093-199040200-00002","article-title":"Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.","volume":"4","author":"Blennow","year":"1990","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1161\/01.STR.0000031927.25510.D1","article-title":"Antiphospholipid antibodies and stroke in young women.","volume":"33","author":"Brey","year":"2002","journal-title":"Stroke"},{"key":"B11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.b75","article-title":"Dementia.","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1471-4159.1995.64010424.x","article-title":"Lipid composition of neuronal cell bodies and neurites from cultured dorsal root ganglia.","volume":"64","author":"Calderon","year":"1995","journal-title":"J. Neurochem."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00045","article-title":"Astrocytes as the main players in primary degenerative disorders of the human central nervous system.","volume":"8","author":"Capani","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1006\/jaut.1998.0214","article-title":"Serum anti-\u03b22-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells.","volume":"11","author":"Caronti","year":"","journal-title":"J. Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","article-title":"Anti-\u03b22-glycoprotein I antibodies bind to central nervous system.","volume":"156","author":"Caronti","year":"","journal-title":"J. Neurol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","article-title":"Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer\u2019s Disease or Vascular Dementia.","volume":"337","author":"Cervellati","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","article-title":"Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants.","volume":"203","author":"Chapman","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00124743-200212000-00010","article-title":"Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome.","volume":"8","author":"Ciubotaru","year":"2002","journal-title":"J. Clin. Rheumatol."},{"key":"B20","first-page":"430","article-title":"Vascular dementia and anticardiolipin antibodies.","volume":"11","author":"de Godoy","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"B21","first-page":"105","article-title":"Anticorpo anticardiolipina: fator de risco para dem\u00eancia vascular?","volume":"7","author":"de Godoy","year":"2000","journal-title":"HB Cient."},{"key":"B22","first-page":"19","article-title":"Alzheimer\u2019s disease and anticardiolipin antibodies.","volume":"5","author":"de Godoy","year":"2012","journal-title":"J. Phlebol. Lymphol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13760-013-0275-6","article-title":"Neurological presentations of the antiphospholipid syndrome: three illustrative cases.","volume":"114","author":"De Maeseneire","year":"2014","journal-title":"Acta Neurol. Belg."},{"key":"B24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1355617797003779","article-title":"The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus.","volume":"3","author":"Denburg","year":"1997","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7748\/ns.29.37.37.e9405","article-title":"Dementia: definitions and types.","volume":"29","author":"Dening","year":"2015","journal-title":"Nurs. Stand."},{"key":"B26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semnephrol.2006.09.006","article-title":"The antiphospholipid syndrome.","volume":"27","author":"Fischer","year":"2007","journal-title":"Semin. Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1155\/2013\/316495","article-title":"Dementia, ataxia and parkinsonism associated with the antiphospholipid syndrome.","volume":"17","author":"Friedman","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome.","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/keh408","article-title":"Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.","volume":"44","author":"Gomez-Puerta","year":"2005","journal-title":"Rheumatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/j.1471-4159.1971.tb09587.x","article-title":"Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions.","volume":"18","author":"Hamberger","year":"1971","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00167","article-title":"Exergaming as a viable therapeutic tool to improve static and dynamic balance among older adults and people with idiopathic Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"7","author":"Harris","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/ard.44.4.281","article-title":"Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies.","volume":"44","author":"Harris","year":"1985","journal-title":"Ann. Rheum. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ene.12316","article-title":"Anticardiolipin antibodies are associated with cognitive dysfunction in stroke-free individuals.","volume":"21","author":"Homayoon","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4933-6-13","article-title":"Pathophysiology of vascular dementia.","volume":"6","author":"Iemolo","year":"2009","journal-title":"Immun. Ageing"},{"key":"B36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000107009","article-title":"The lupus anticoagulant and dementia in non-SLE patients.","volume":"3","author":"Inzelberg","year":"1992","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417694881","article-title":"Coexistence of antiphospholipid antibodies and cephalalgia.","author":"Islam","year":"","journal-title":"Cephalalgia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.autrev.2017.03.005","article-title":"Comorbid association of antiphospholipid antibodies and migraine: a systematic review and meta-analysis.","volume":"16","author":"Islam","year":"","journal-title":"Autoimmun. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2174\/1568026617666170103163054","article-title":"Alzheimer\u2019s disease and natural products: future regimens emerging from nature.","volume":"17","author":"Islam","year":"","journal-title":"Curr. Top. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2174\/1871527315666160920122750","article-title":"\u2018Non-criteria\u2019 neurologic manifestations of antiphospholipid syndrome: a hidden kingdom to be discovered.","volume":"15","author":"Islam","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1076\/jcen.21.2.251.931","article-title":"Neuropsychological deficits associated with antiphospholipid antibodies.","volume":"21","author":"Jacobson","year":"1999","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","article-title":"Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack.","volume":"35","author":"Janardhan","year":"2004","journal-title":"Stroke"},{"key":"B43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/096120339500400611","article-title":"Anticardiolipin antibodies in two elderly subpopulations.","volume":"4","author":"Juby","year":"1995","journal-title":"Lupus"},{"key":"B44","first-page":"4","article-title":"Prevalence and disease associations of certain autoantibodies in elderly patients.","volume":"21","author":"Juby","year":"1998","journal-title":"Clin. Invest. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors.","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neurobiolaging.2009.02.007","article-title":"Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background.","volume":"32","author":"Katzav","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12016-009-8154-x","article-title":"The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.","volume":"38","author":"Katzav","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B48","first-page":"1725","article-title":"Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system.","volume":"24","author":"Kent","year":"1997","journal-title":"J. Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/exnr.2000.7358","article-title":"Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain.","volume":"163","author":"Kent","year":"2000","journal-title":"Exp. Neurol."},{"key":"B50","first-page":"34","article-title":"Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.","volume":"32","author":"Kozora","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2169\/internalmedicine.33.373","article-title":"A young case with multi-infarct dementia associated with lupus anticoagulant.","volume":"33","author":"Kurita","year":"1994","journal-title":"Intern. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/01.STR.21.2.295","article-title":"Prospective study of anticardiolipin antibodies in stroke.","volume":"21","author":"Kushner","year":"1990","journal-title":"Stroke"},{"key":"B53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mrm.1910060307","article-title":"Phospholipid profile of the human brain: 31P NMR spectroscopic study.","volume":"6","author":"Kwee","year":"1988","journal-title":"Magn. Reson. Med."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00082","article-title":"Glucose tightly controls morphological and functional properties of astrocytes.","volume":"8","author":"Lee","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/01.STR.18.6.1101","article-title":"Ischemic stroke associated with anticardiolipin antibodies.","volume":"18","author":"Levine","year":"1987","journal-title":"Stroke"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/acr.22914","article-title":"Increased risk of dementia in patients with systemic lupus erythematosus: a nationwide population-based cohort study.","volume":"68","author":"Lin","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/01.STR.23.8.1078","article-title":"Serum autoantibodies in patients with Alzheimer\u2019s disease and vascular dementia and in nondemented control subjects.","volume":"23","author":"Lopez","year":"1992","journal-title":"Stroke"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/504678","article-title":"The role of oxidative damage in the pathogenesis and progression of Alzheimer\u2019s disease and vascular dementia.","volume":"2015","author":"Luca","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/858542","article-title":"\u201cNew\u201d antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.","volume":"2015","author":"Misasi","year":"2015","journal-title":"J. Immunol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"B61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000017211","article-title":"Dementia and antiphospholipid antibodies.","volume":"11","author":"Mosek","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(94)91775-2","article-title":"Anticardiolipin antibodies in an unselected stroke population.","volume":"344","author":"Muir","year":"1994","journal-title":"Lancet"},{"key":"B63","author":"Prince","year":"2016","journal-title":"World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia - Coverage, Quality and Costs now and in the Future"},{"key":"B64","author":"Prince","year":"2014","journal-title":"Dementia UK: Update"},{"key":"B65","author":"Prince","year":"2015","journal-title":"World Alzheimer\u2019s Report 2015: The Global Impact of Dementia. Alzheimer\u2019s Disease International - An Analysis of Prevalence, Incidence, Cost and Trends"},{"key":"B66","first-page":"80","article-title":"Investigation of relations between anti-cardiolipin antibodies and intima membrane thickness, carotid artery stenosis in patients with vascular dementia.","volume":"5","author":"Qian","year":"2015","journal-title":"Chin. J. Brain Dis. Rehabil."},{"key":"B67","year":"2014","journal-title":"Review Manager (Revman) [Computer Program]. Version 5.3"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3029","article-title":"Dementia: timely diagnosis and early intervention.","volume":"350","author":"Robinson","year":"2015","journal-title":"BMJ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1532-5415.5155.x","article-title":"Vascular dementia: distinguishing characteristics, treatment, and prevention.","volume":"51","author":"Rom\u00e1n","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"key":"B70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/01.STR.26.5.749","article-title":"Anticardiolipin antibodies in normal subjects.","volume":"26","author":"Schmidt","year":"1995","journal-title":"Stroke"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/ar1892","article-title":"Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.","volume":"8","author":"Steens","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"B73","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/ard.51.6.707","article-title":"Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum.","volume":"51","author":"Sun","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"B74","first-page":"3","article-title":"Study on the correlation between antiphospholipid antibodies and vascular dementia.","volume":"41","author":"Tan","year":"2001","journal-title":"Shandong Med. J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/neup.12262","article-title":"Blood-brain barrier damage in vascular dementia.","volume":"36","author":"Ueno","year":"2015","journal-title":"Neuropathology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neubiorev.2014.11.022","article-title":"Blood\u2013brain barrier impairment in dementia: current and future in vivo assessments.","volume":"49","author":"van de Haar","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1212\/WNL.46.6.1599","article-title":"Reversible dementia and chorea in a young woman with the lupus anticoagulant.","volume":"46","author":"Van Horn","year":"1996","journal-title":"Neurology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"B79","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-0404.1990.tb01562.x","article-title":"Blood brain barrier function in vascular dementia.","volume":"81","author":"Wallin","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"B80","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000008242","article-title":"Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.","volume":"44","author":"Wallin","year":"2000","journal-title":"Eur. Neurol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2016-207809","article-title":"Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK.","author":"Wotton","year":"2017","journal-title":"J. Epidemiol. Community Health"},{"key":"B82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis.","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/ard.50.12.903","article-title":"Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis.","volume":"50","author":"Yu","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"B84","first-page":"635","article-title":"Studies on correlation of anticardiolipin antibodies and multi-infarct dementia.","volume":"19","author":"Zeng","year":"2006","journal-title":"Acta Med. Sin."},{"key":"B85","first-page":"353","article-title":"Detection of anticardiolipin antibodies in patients with Binswanger\u2019s disease.","volume":"40","author":"Zhao","year":"2004","journal-title":"J. Qingdao Univ. Med. Coll."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:02:26Z","timestamp":1569970946000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":85,"alternative-id":["10.3389\/fnagi.2017.00250"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2017.00250","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]},"article-number":"250"}}